Likewise, our team demonstrated that in Angptl2-knockdown mouse model exhibiting mild aortic valve stenosis and LV systolic dysfunction, cardiac-specific deletion of NOX4 using AAV9-sh-NOX4 attenuated LV contractile dysfunction and increased cardiac antioxidant response [105] (Table 4). This evidence concerns the gene NOX4 and aortic valve stenosis.